Reunion Neuroscience Inc.
PrivateLast Round
Series A
Extension
Sep 16, 2025
Est. Valuation
$13.1M
Total Funding Raised
$229.73M
Company Overview
Reunion Neuroscience Inc. operates in Healthcare & Life Sciences and is based in Morristown, New Jersey. Its latest recorded funding round was a Series A Extension round in September 2025.
Reunion Neuroscience Inc. is a clinical-stage biopharmaceutical company that develops psychedelic-inspired therapeutic solutions for underserved mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reunion Neuroscience Inc. Comparables
Compare Reunion Neuroscience Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gilgamesh Pharma Inc. | 86% | |
| Cybin Inc. | 83% | |
| GH Research | 83% |
For institutional investors. Book with your work email.
Reunion Neuroscience Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 16, 2025 | ||||
| Series A | May 2, 2024 | ||||
| Early Stage VC | Jan 12, 2024 | ||||
| Take Private | Aug 1, 2023 | ||||
| M&A | Jun 1, 2023 | ||||
Corporate Funding | Nov 18, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reunion Neuroscience Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Follow-on Offering |
| Chicago Atlantic BDC Advisers | Series A |
| Mitsui Global Investment | Series A, Series A Extension |
| Jennison Associates | Follow-on Offering |
| Bolt | Series A, Seed |
| MPM BioImpact | Series A, Take Private, M&A, Series A Extension |
| Plaisance Capital Management | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2024
$103M round completed.
- Jan 12, 2024
$120M raised in early stage VC funding.
For institutional investors. Book with your work email.
Reunion Neuroscience Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reunion Neuroscience Inc.'s valuation, stock price, and market status.
Is Reunion Neuroscience Inc. a public or private company?
Reunion Neuroscience Inc. is a private company.
What is the current stock price of Reunion Neuroscience Inc.?
Reunion Neuroscience Inc. is a private company, so its shares have no public market price. Caplight tracks Reunion Neuroscience Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reunion Neuroscience Inc. worth (valuation)?
Reunion Neuroscience Inc.'s valuation is estimated at $13.1M based on funding round data.
Can I buy Reunion Neuroscience Inc. stock?
Reunion Neuroscience Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reunion Neuroscience Inc.'s last funding round?
Reunion Neuroscience Inc.'s most recent funding round was Series A Extension on September 16, 2025.
Who are the main investors in Reunion Neuroscience Inc.?
Key investors in Reunion Neuroscience Inc. include Soleus Capital, MPM BioImpact, Novo Holdings, Nikean Foundation.
Will Reunion Neuroscience Inc. IPO soon?
No public IPO plans have been announced for Reunion Neuroscience Inc..
How can I track Reunion Neuroscience Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Reunion Neuroscience Inc.'s shares on secondary markets.